http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0679101-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dc257bb71addfc9d350ea7048ac1f02 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-369 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3606 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3621 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3692 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-18 |
filingDate | 1992-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68ee598c999763d82ecd0e1383d5e367 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c73e7ad87f53dde34f0df20b99f83818 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2fecf2a1e9e61cc9de171ff52882127 |
publicationDate | 1995-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0679101-A1 |
titleOfInvention | APPARATUS FOR ADMINISTRATING MEDICINES IN RED BLOOD CELLS. |
abstract | PCT No. PCT/FR92/00623 Sec. 371 Date Jan. 3, 1994 Sec. 102(e) Date Jan. 3, 1994 PCT Filed Jul. 2, 1992 PCT Pub. No. WO93/00940 PCT Pub. Date Jan. 21, 1993An apparatus for incorporating one or more biologically active substances into red blood corpuscles (erythrocytes) by lysis and resealing technique comprises a washing unit, a lysis unit and a resealing unit. The washing unit obtains a suspension of erythrocytes from complete or incomplete blood. The lysis unit cools the erythrocyte suspension to a temperature below 10 DEG C. and maintains this temperature while the suspension is processed through a dialysis unit and subsequently exposed to the active substance. The treated erythrocyte suspension is held in a retardation pouch for a predetermined time and thereafter fed to the resealing unit, which heats the treated suspension to a temperature higher than 20 DEG C. and maintains this temperature while the treated suspension is exposed to the resealing product. The suspension exposed to the resealing product is collected in a collecting pouch for a predetermine period before it is discharged to the washing unit. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010076517-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013139906-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2277594-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2813234-A1 |
priorityDate | 1991-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.